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Here we investigate the biochemical, molecular, and
cellular changes directed toward blood pressure home-
ostasis that occur in the endocrine branch of the renin-
angiotensin system of mice having one angiotensinogen
gene inactivated. No compensatory up-regulation of the
remaining normal allele occurs in the liver, the main
tissue of angiotensinogen synthesis. No significant
changes occur in expression of the genes coding for the
angiotensin converting enzyme or the major pressor-
mediating receptor for angiotensin, but plasma renin
concentration in the mice having only one copy of the
angiotensinogen gene is greater than twice wild-type.
This increase is mediated primarily by a modest in-
crease in the proportion of renal glomeruli producing
renin in their juxtaglomerular apparatus and by four
times wild-type numbers of renin-producing cells along
afferent arterioles of the glomeruli rather than by up-
regulating renin production in cells already committed
to its synthesis.
An essential feature of complex organisms is the ability to
maintain near constancy of their internal environments. Ho-
meostasis is maintained by the operation of sophisticated sys-
tems that permit desirable physiological changes in biological
variables, but that also act homeostatically if external factors
cause undesirable changes in the variables. Genetic heteroge-
neity, such as is inherent to all outbred species including hu-
mans, also tends to cause variation in the internal environ-
ment. Yet the extent and types of homeostatic changes induced
by naturally occurring genetic differences have not received
much attention. We have recently been carrying out experi-
ments aimed at identifying genes whose quantitative expres-
sion affects an important biological variable, blood pressure. To
this end, we have used gene targeting in mice to alter the
number of functional copies of several candidate genes, and so
to produce systematic changes in their expression of the same
order of magnitude as those occurring naturally in humans.
Since the resulting mice are in other respects wild-type, their
homeostatic systems are intact, and the mice can be used to
investigate what compensations have been induced by the ge-
netically determined differences in expression of the “titrated”
genes. Because the causative genetic changes are life long, any
induced compensations are categorically comparable with the
lifelong adjustments that individual humans make in adjusting
to the genetic heterogeneity inherent to our species.
The renin-angiotensin system (RAS)1 is critical for control-
ling blood pressure and salt balance in mammals. Angio-
tensinogen (AGT) is the sole source of angiotensin II (AngII),
the major active peptide of the system. AGT is synthesized
primarily in the liver and is secreted constitutively into the
blood stream. It is the substrate for renin, a highly specific
protease whose only known substrate is AGT. The majority of
renin synthesis and secretion into the blood stream in normal
mature animals is by modified smooth muscle cells in the
juxtaglomerular apparatus (JGA) of the kidney. The action of
renin on AGT produces the decapeptide angiotensin I (AngI),
which has no significant cardiovascular activity. Angiotensin-
converting enzyme, ACE, a dipeptidase present in the blood
stream as a circulating protein and in tissues as a membrane
bound protein, converts AngI to the vasoactive octapeptide
AngII. Genetic heterogeneity has been demonstrated at the
angiotensinogen locus in humans (1, 2), and two common
alleles are associated with quantitative differences in the
plasma concentration of AGT and with differences in blood
pressure. In previous experiments (3, 4) quantitative differ-
ences in expression in mice of the angiotensinogen gene (Agt)
have been shown to directly cause modest changes in blood
pressure. Here we explore the long term homeostatic adjust-
ments that occur in mice attempting to restore their blood
pressures to normal in the face of inheriting below normal
expression of the angiotensinogen gene (Agt).
EXPERIMENTAL PROCEDURES
Animals—Except as indicated, all mice used were F1 hybrids be-
tween the inbred strains 129 and B6 with or without a disruptive
mutation in the 129-derived copy of the Agt gene. The mutation in the
Agt gene was generated in embryonic stem cells from the substrain
129/OlaHsd (5). Prior to the matings to produce the F1 hybrids, the Agt
gene mutation had been maintained for several generations on the
closely related substrain 129/J. The mice were fed regular chow and
handled following the National Institutes of Health guidelines for the
care and use of experimental animals.
Protein Studies—Blood samples were rapidly withdrawn from the
descending aorta of mice after exposure to an atmosphere of CO2 (less
than 1 min from loss of consciousness to the end of collection). The blood
was collected into ice-cold microcentrifuge tubes containing EDTA and
was immediately centrifuged to isolate plasma. Plasma AGT and (ac-
tive) renin concentrations were determined by radioimmunoassay as
described previously (4). Plasma prorenin concentrations were deter-
mined after conversion to active renin by the trypsin-Sepharose 4B
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method (6). ACE activity was measured by the cleavage of a chromo-
genic tripeptide (7), using serum isolated from blood collected retro-
orbitally without anticoagulant.
Plasma Peptide Measurement—Blood handling and radioimmunoas-
says followed published methods (8, 9) with slight modifications. Pep-
tides were extracted with ethanol as described in the assay procedure
from the Nichols Institute (San Juan Capistrano, CA) using 600 ml of
plasma pooled from three individuals matched by genotype and gender.
The extracted peptide samples were divided into three equal portions
and dried in a vacuum centrifuge. Single portions were used for meas-
urement of AngI, AngII, or bradykinin. Recoveries of each peptide at
completion of the extraction procedure were determined by 1125-labeled
tracers to be approximately 80%. By using highly specific monoclonal
antibodies for the measurements, the radioimmunoassays could be
carried out without further separations. The radioimmunoassays were
performed with commercially available kits for AngI (DuPont), AngII
(Nichols), and bradykinin (Peninsula, Belmont, CA).
RNA Isolation—Tissues were rapidly dissected after withdrawing
blood. Total RNA was isolated conventionally (10) using the TRI RE-
AGENTTM procedure (Molecular Research Inc., Cincinnati, OH).
Riboprobes and Sense RNA Preparation—DNA fragments from the
Agt, renin, and b-actin genes were prepared by PCR using strain
129/OlaHsd mouse genomic DNA as the template and the following
probes designed from published sequences: a 390-bp exon 2 fragment
from the Agt gene (11); a 290-bp exon 9 fragment from the mouse renin
gene Ren-1d (12); and a 250-bp fragment from the mouse b-actin gene
(13). A 418-bp fragment corresponding to nucleotides 2523–2931 of
mouse ACE cDNA (14) was cloned after RT-PCR using total RNA from
the lung as template. All of the fragments were subcloned into a Blue-
script(KS) vector for in vitro transcription (15). 32P-Labeled antisense
riboprobes were synthesized by the manufacturer’s protocols using a
MAXI scriptTM transcription kit (Ambion Inc., Austin, TX). Unlabeled
sense RNAs were prepared with the same transcription system. The
sense RNAs were gel-purified and stored at 270 °C.
RNase Protection Assay—The procedure described by Azrolan and
Breslow (16) with minor modifications was used for RNase protection
assay. All reactions were carried out in duplicate for each sample in all
experimental groups. A standard curve was generated using sense
RNAs.
Primer Extension Analysis—Primer preparation and primer exten-
sion analysis for the mouse renin genes were slightly modified versions
of published procedures (17, 18). The primer was a 38-mer oligonucleo-
tide complementary to Ren-1C mRNA from positions 1039 through 1076
of the cDNA sequence (19). We determined that the nucleotide sequence
of this region is identical in the strain B6 Ren-1c gene and the strain 129
Ren-1d and Ren-2 genes. Autoradiographic bands were quantitated with
an NIH image computer program (version 1.55).
RT-PCR Assay—Quantitative RT-PCR (20) was used to assess ex-
pression of the gene coding for the type 1A receptor for AngII. Total
RNA from the kidney was reversely transcribed to cDNA (21). A tem-
plate plasmid for preparing the internal standard was constructed by
making a 120-bp deletion (PvuII/DraI sites) in a PlmI/SacI fragment
from the mouse type 1A receptor gene. PCR primers specific for the type
1A gene were designed from sequences of the type 1A and 1B genes (22);
they are 59-ACGAGTCCCGGAATTACACG-39 for the sense primer and
59-GCGTGCTCATTTTCGTAGACAGG-39 for the antisense primer.
Competitive PCR was performed in the presence of an internal stand-
ard, yielding a 320-bp fragment. The RT product corresponding to the
type 1A mRNA is 440 bp long. The amount of the full-length product
relative to the internal standard was determined after hybridization to
labeled full-length fragment as a probe.
Renin Immunocytochemistry in Kidney Sections—Immunohisto-
chemical detection of renin was as described previously (23, 24). Briefly,
after deparaffinization, 7-mm kidney sections were incubated with a
polyclonal renin antibody (1:10,000, gift from Dr. Tadashi Inagami,
Vanderbilt University, Nashville, TN). The high specificity and charac-
terization of this renin antibody has been documented previously (25).
Immunocytochemistry was done with kidneys from the Agt one-copy
and wild-type mice. Two to four sections per kidney were examined by
direct microscopic visualization. The total number of glomeruli, the
number with renin-positive JGA, and the number with renin-positive
cells upstream of the JGA were counted in each section. The percentage
of renin-positive JGA was determined as (the number of renin-positive
JGA in all sections) 3 100/(the total number of glomeruli observed). The
number of cells positive for renin, including those in the JGA itself,
along the afferent arterioles of glomeruli having upstream renin-posi-
tive cells was also counted in each section. The figures thus obtained
from each slide were averaged for each animal.
To determine the area of juxtaglomerular apparatuses in the Agt
one-copy and wild-type mice, 10 random fields of each section were
captured with a video camera. Every section was screened using the
same magnification (3 400), and only the JGA with a classic donut-
shaped outline were evaluated. All the images were studied with an
image analysis software (MochaTM, version 1.02, Jandel Scientific).
Using the manual measurement mode, the perimeter of each JGA was
outlined, and its area was determined by summing the number of pixels
contained within the outline.
To determine the number of cells in the JGA that had been evaluated
for area, the number of nuclei observed within the outlined perimeter
was counted.
Microvascular Dissection—To obtain an integrated view of the dis-
tribution of renin within the kidney, the entire renal arterial tree was
dissected as described previously in rats and mice (26, 27) and stained
for renin. The distribution of renin within the kidney was classified as
described previously (28). In a type I distribution, renin is present along
the whole length of the afferent vessel. In type II, renin extends up-
stream from the glomerulus but does not occupy the whole length of the
vessel. In type III, renin is present as rings along the afferent vessel. In
type IV, renin is restricted to the classical juxtaglomerular localization.
In type V, no renin is found in the arteriole.
Statistics—All values are expressed as mean 6 S.E. The two-tailed t
test was used for statistical evaluations.
RESULTS
The Experimental Animals—The experimental animals used
for investigating long term homeostatic compensations in the
RAS have a single functional copy of the Agt gene and one
disrupted by gene targeting. We refer to them as Agt one-copy
mice, and their blood pressures are about 8 mmHg (approxi-
mately 7%) below the pressures of wild-type mice with two
copies of the gene (4). Except when indicated, the mice studied
were F1 progeny-derived from the two inbred strains 129 and
C57BL/6 (B6) and so were genetically identical except for hav-
ing different numbers of functional Agt genes. Because of this
genetic uniformity, even small differences between the mice
can be ascribed directly to the difference in Agt gene copy
number.
Renin-Angiotensin System Proteins and Peptides—To deter-
mine what components are homeostatically adjusted in the Agt
one-copy animals, the steady state concentrations of the major
RAS protein components present in plasma were compared in
the Agt one-copy animals and their wild-type controls. The
resulting data, Table I and Fig. 1 (below), show two major
differences. First, the plasma AGT concentration in the Agt
one-copy mice is markedly reduced, to 33–37% of the AGT
concentration in the controls (p , 0.01), which is also signifi-
cantly less than the 50% expected if the amount of protein were
directly related to gene copy number (p , 0.01 versus 50%). A
possible complication affecting this observation is that the
functional Agt gene in the one-copy animals is derived from
mouse strain B6, whereas the wild-type two-copy animals have
one copy from strain B6 and one from strain 129. However, a
comparison of AGT levels in wild-type inbred strain B6 and 129
mice shows that B6 mice have higher AGT levels (558 6 30
AngI ng/ml/h, in six females) than do 129 mice (426 6 11 AngI
ng/ml/h, in six females), so that if strain differences in Agt gene
expression persist in the F1 hybrids, the AGT concentration in
the Agt one-copy animals should be even more than 50% of the
wild-type F1 animals. We conclude that the plasma concentra-
tion of AGT shows no evidence of any compensatory increase in
the Agt one-copy animals.
The second major difference is that, in marked contrast to
the absence of any detectable compensation in AGT plasma
concentration, the plasma renin concentration in the Agt one-
copy animals is very significantly higher (240%) than in the
wild-type controls (p , 0.001), indicating a marked homeostatic
adjustment in this component of the RAS.
In mice and humans, renin is secreted into the circulation by
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renin-producing cells partly as enzymatically inactive prorenin
and partly as enzymatically active renin (29). The observed
homeostatic increase in plasma renin could therefore be partly
or wholly the consequence of a change in the proportion of the
secreted protein in the active versus inactive form of renin. To
investigate this possibility, we determined the plasma concen-
tration of prorenin in Agt one-copy and in wild-type animals as
well as the concentration of (active) renin. The plasma prorenin
concentration in the Agt one-copy male animals was signifi-
cantly higher (234%; p , 0.01) than in the wild-type controls
(Table I). This increase in plasma prorenin is virtually identical
to that of the plasma active renin, so that the same ratio of
prorenin and active renin is observed in Agt one-copy and
wild-type mice. We conclude that a change in the ratio of these
two products is not part of the homeostatic adjustment made in
the Agt one-copy mice.
To determine the net effect of the observed increase in
plasma renin concentration combined with the observed de-
crease in plasma AGT concentration, we compared the steady
state concentrations of AngI in Agt one-copy and wild-type
mice. The results show that the Agt one-copy animals have
AngI levels that are 58% and 75% of wild-type in males and
females, respectively. Thus the combined effect of the two
changes is a partial but not complete restoration of the AngI
concentrations to the wild-type level (p , 0.001 for one-copy
versus wild-type), albeit at the expense of decreasing the steady
state concentration of AGT below 50% of wild-type.
An additional possible means of compensating for the less
than normal AGT and AngI plasma levels in the one-copy
animals would be via a homeostatically induced increase in the
level of the converting enzyme ACE. Measurements of serum
ACE activities (Table I), however, show no significant differ-
ences (p 5 0.15) between the Agt one-copy mice and the wild-
type controls. An additional indicator of possible changes in
ACE function is the plasma bradykinin concentration, since
this octapeptide is destroyed by the enzyme. We found that the
bradykinin levels were not different between the Agt one-copy
mice and the wild-type mice (p 5 0.87). Thus we conclude that
homeostatic compensation has not been induced at the level of
the converting enzyme or of the bradykinin peptide.
The major effector peptide of the RAS is the octapeptide
AngII. A measure of changes in the net status of the circulating
arm of the system can therefore be obtained by comparing the
steady state plasma concentrations of AngII in Agt one-copy
and wild-type mice. The resulting data show that plasma AngII
in the Agt one-copy males and females are, respectively, 50%
and 62% of the levels in the wild-type animals. These levels are
significantly less than wild-type (p , 0.01), indicating that
homeostasis is incomplete, as is reflected by the residual dif-
ferences in blood pressure between Agt one-copy and wild-type
animals.
In summary, (Fig. 1), measurements of the expression of the
protein and peptide components of the endocrine RAS show
clear evidence that a major homeostatic compensation occurs in
plasma renin concentrations in response to a genetic reduction
in Agt gene expression. Other components of the system either
show no changes or have changes that appear to be passive and
secondary to the genetic reduction in AGT levels and the con-
sequent homeostatic increase in renin. The final result is a
steady state concentration of AngII in Agt one-copy animals
that is still significantly less than normal.
Renin-Angiotensin System mRNAs—To ascertain whether
the changes seen in the circulating protein components of the
RAS are present at the level of transcriptional products, we
used an RNase protection assay to determine the amounts of
the relevant mRNAs in tissues that make the largest contribu-
tion to the plasma in Agt one-copy and wild-type animals. The
major site of synthesis of AGT secreted into blood is the liver
(30), which also contains the highest abundance of AGT mRNA.
Fig. 2A presents the data for AGT mRNA in Agt one-copy and
wild-type F1 males and females and in strain B6 and 129
inbred wild-type males. More mRNA is present in the female
mice than in the males (a disparity also observed in the plasma
AGT). But regardless of gender the liver AGT mRNA levels in
Agt one-copy animals are clearly reduced compared with those
in the wild-type animals (54% in males; 53% in females; p ,
0.001). Recollecting that the single functional Agt gene in the
one-copy animals is derived from strain B6 and noting from
TABLE I
Plasma proteins and peptides in F1 Agt wild-type and F1 Agt one-copy mice
AGT, renin, and prorenin: ng of AngI/ml/h. ACE activity: units/liter. AngI, AngII, and bradykinin: pg/ml. Values are means 6 S.E. Values in
parentheses are percent relative to wild-type. n, number of animals; ND, not determined; wt, wild type.
Males Females
n Agt wt Agt one-copy Agt wt Agt one-copy
AGT 6 498 6 23 164 6 6 (33)a 550 6 14 201 6 16 (37)a
Renin 6 38 6 1 85 6 6 (222)b 50 6 4 131 6 12 (262)b
Prorenin 6 244 6 3 572 6 51 (234)a ND ND
ACE 3 400 6 29 360 6 15 (90)c 246 6 15 251 6 11 (102)c
AngI 3 59 6 3 34 6 4 (58)b 60 6 2 45 6 3 (75)b
AngII 3 23 6 5 12 6 1 (50)a 18 6 1 11 6 2 (62)a
Bradykinin 3 94 6 4 96 6 2 (103)d 70 6 2 64 6 1 (93)d
a p , 0.01 versus wild-type.
b p , 0.001 versus wild-type.
c p 5 0.15 versus wild-type.
d p 5 0.87 versus wild-type.
FIG. 1. RAS proteins and peptides in Agt one-copy mice. A,
inter-relationships of the components measured in the RAS cascade. B,
levels of the RAS components in Agt one-copy mice. The bars show
means 6 S.E. as percentages of those in wild-type mice (Agt two-copy).
See Table I and Fig. 3 for details.
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Fig. 2A that liver AGT mRNA levels in strain B6 are 1.2 times
the corresponding levels in strain 129, we conclude that the
liver AGT mRNA data agree with the plasma protein data in
indicating no homeostatic compensation in the Agt one-copy
mice in the transcription of the remaining functional Agt gene
in the primary tissue of AGT synthesis.
The high steady state plasma renin (and prorenin) concen-
trations observed in Agt one-copy animals suggest a substan-
tially increased level of renin gene transcription. Fig. 2B pre-
sents the relevant data and shows that the steady state renin
mRNA contents of the kidneys of the Agt one-copy males and
females are respectively 182 and 165% of the wild-type two-
copy controls (p , 0.001). Thus a major part of the homeostatic
adjustment in renin production is a consequence of an increase
in amount of renin mRNA.
Since the steady state serum ACE activities of the experi-
mental and control mice do not differ significantly, we expected
to see no differences in the ACE mRNA levels in tissues in
which ACE is synthesized. The lungs are a major site of ACE
synthesis in both sexes (31). In addition, a truncated form of
ACE is synthesized in the testis from a testis-specific promoter
(32). Fig. 2C presents data showing that the ACE mRNA con-
tents of the lungs of Agt one-copy males and females are
slightly increased (108 and 105%) relative to their two-copy
controls, but the difference is not statistically significant (p 5
0.09). The ACE mRNA level in the testis was also slightly
higher (data not shown), but again the difference was not
significant (108% wild-type, p 5 0.65). Thus there is no evi-
dence for significant homeostatic compensation at the level of
ACE mRNA.
In the mouse, three receptors (types 1A, 1B, and 2) control
the cellular and physiologic actions of AngII (22, 33). The
results of administering receptor antagonists that specifically
block the actions of either the type 1 or the type 2 receptors
establish that blood pressure changes are chiefly executed by
the type 1 receptors (34). Genetic experiments disrupting the
genes coding for the type 1A receptor gene (35, 36) or the type
1B receptor gene (37, 53) show that approximately 90% of the
endocrine pressor effects of AngII are via by the type 1A recep-
tor. Another possible means of homeostatic adjustments in the
face of a chronic decrease in blood pressure would therefore be
to increase expression of the type 1A receptor. However, com-
parison of the type 1A receptor gene expression by RT-PCR
(Fig. 3) in Agt wild-type mice (lane 1) and the Agt one-copy mice
(lane 2) revealed no detectable differences, although the same
assay readily detected the decreased level of type 1A receptor
mRNA in animals having only one copy of the 1A receptor gene
(lane 4) in place of the normal two copies (lane 3), and showed
no product in 1A receptor gene zero-copy mice (lane 5). Thus
chronic homeostatic changes in expression of the type 1A an-
giotensin II receptor gene do not occur in the Agt one-copy
animals.
Other Tissues—A great deal of work by many investigators
has been directed toward assessing the possible autocrine/
paracrine contributions to blood pressure homeostasis by RAS
components synthesized in tissues other than those directly
involved in the endocrine/circulatory aspects of the system (38,
39). Homeostatic changes in other tissues were therefore inves-
tigated in the Agt one-copy and wild-type animals. The data for
AGT mRNA are summarized in Fig. 4A and show that, as in the
liver, the AGT mRNA levels in the kidney, submandibular
gland and testis of the Agt one-copy animals are close to the
levels expected for animals having only a B6-derived Agt gene.
Thus there is no evidence of significant homeostatic compen-
sation at the level of Agt gene transcription in these tissues. In
the brains of both males and females, the Agt one-copy animals
likewise have lower amounts of AGT mRNA than wild-type
animals, but the difference in the brain is less than in all other
tissues. Further studies will be required to determine whether
this is due to a compensatory change in Agt gene expression in
the brain or to some other factors.
Fig. 4B presents the data for renin mRNA levels in various
extra-renal tissues. With one exception, renin mRNA in extra-
renal tissues does not differ between the Agt one-copy and
wild-type animals. The exception is the adrenal gland of males,
where the level of adrenal renin mRNA in Agt one-copy males
FIG. 2. Tissue mRNA levels for primary tissues synthesizing
AGT, renin, and ACE determined by RNase protection assay. A,
AGT mRNA in the liver. n 5 10 for each of the four groups of F1 mice;
n 5 5 for the wild-type B6 and 129 males. B, renin mRNA in the kidney.
n 5 10 for each group of F1 mice; n 5 5 for the wild-type B6 and 129
males and females. C, ACE mRNA in the lung. n 5 5 for each group of
F1 mice. The bars show means 6 S.E. Asterisks indicate Agt one-copy
means significantly different from wild-type means (p , 0.001).
FIG. 3. Comparisons by RT-PCR of type 1A angiotensin II re-
ceptor mRNA in Agt one-copy and wild type mice. The products of
25 cycles of PCR with reverse transcripts from the kidneys of five mice
are visualized. The 440-bp band is the product from the mouse type 1A
receptor mRNA; the 320-bp product is from a PCR internal standard.
The genotypes of the mice were: Agt wild-type, 1A receptor wild-type
(lane 1); Agt one-copy, 1A receptor wild-type (lane 2); Agt wild-type, 1A
receptor wild-type (two-copy) (lane 3); Agt wild-type, 1A receptor one-
copy (lane 4); Agt wild-type, 1A receptor zero-copy (lane 5).
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is four times that of wild-type males (p , 0.001). However, no
difference in adrenal renin mRNA is seen between the Agt
one-copy and wild-type females (p 5 0.48). Note also that Agt
wild-type males have approximately four times the adrenal
renin mRNA of wild-type females, so that gender-related dif-
ferences in renin expression are seen in the adrenal glands
irrespective of their Agt genotypes.
Gender-related Effects—Some strains of mice including 129
have a duplicated renin locus that includes a closely linked
androgen-responsive renin gene (Ren-2) in addition to a gen-
der-indifferent gene (Ren-1); male mice carrying the Ren-2 gene
synthesize large amounts of mRNA in their submandibular
glands and secrete renin into their saliva (40, 41). Other
strains, including B6 (and humans), have only the Ren-1 gene,
and so have much lower salivary gland renin mRNA levels,
comparable with the levels seen in females. The Ren-2 gene has
not been described in any species other than mouse. The F1
mice used in the present study have the single strain B6-
derived Ren-1c gene and the two closely linked strain 129-
derived Ren-2 and Ren-1d genes. We therefore carried out ex-
periments to determine to what extent the homeostatic
changes in renin expression seen in the Agt one-copy animals
differed by locus as well as by gender.
The relative contribution to kidney renin mRNA of the Ren-1
and Ren-2 genes was determined by a primer extension anal-
ysis. We found that in the Agt one-copy females 20% of the
renin mRNA was derived from the Ren-2 gene, which does not
differ significantly from the percentage in their wild-type sis-
ters or in a 50/50 mixture of the two female parental mRNAs.
In the Agt one-copy males 40% of the mRNA was from the
Ren-2 gene, which is greater than that in their wild-type broth-
ers (10%) or in a 50/50 mixture of the two male parental
mRNAs (10%). Thus, in Agt one-copy females the homeostatic
increase in renin expression is mediated by the two renin genes
in the same proportion as they are expressed in their wild-type
sisters, but in males a greater proportion of the increase is
mediated by the androgen-sensitive Ren-2 gene.
Cellular Responses—A great preponderance of evidence sup-
ports the view that the kidney is the chief source of circulating
active renin and its enzymatically inactive precursor prorenin
in humans and mice (42). In the normal kidney, renin is pro-
duced by modified smooth muscle cells that are associated
mainly with the juxtaglomerular apparatus (JGA) and to a
much lesser extent with the afferent upstream (proximal) por-
tion of the glomerular arterioles. Several, not necessarily mu-
tually exclusive, mechanisms could therefore mediate the
chronic homeostatic elevation of kidney renin mRNA that we
observe. Transcription of one or more of the renin genes could
be up-regulated in the usual renin-producing cells of the kid-
ney, or the number of these or other cells capable of synthesiz-
ing renin could be increased. To help distinguish between these
various possibilities we determined by immunohistochemistry
the number and distribution of renin-containing cells in the
kidneys of Agt one-copy animals and wild-type controls.
The immunohistochemical results are illustrated and dia-
grammed in Fig. 5. In wild-type animals the majority of renin-
producing cells are confined to the juxtaglomerular end of the
arterioles in the manner typical of a classical JGA (Fig. 5, A
and C). This distribution of expression corresponds to the type
IV pattern (28) shown diagrammatically in the bottom panel of
Fig. 5. A much smaller proportion of wild-type glomeruli have
additional renin-staining cells extending along the afferent
arterioles as well as being present in the JGA (types II and III).
Some wild-type glomeruli have no renin-staining cells (type V).
In the Agt one-copy animals (Fig. 5, B and D), there is a
considerable increase in the proportion of glomeruli having
renin-staining cells extending along the afferent arteriole as
well as being present in the JGA (types II, III, and mixed types
II/III and III/IV).
A summary of a statistical analysis of these immunochemical
data is presented in the upper portion of Table II, using com-
bined data from 12-week-old F1 Agt one-copy (n 5 5) and
wild-type mice (n 5 5) and from 10-week-old F2 litter mates
having the same genotypes (n 5 5 and 3, respectively); the F1
and F2 data were essentially indistinguishable. This analysis
shows: (i) that the proportion of glomeruli having renin-stain-
ing cells in the classical JGA region is somewhat (about 25%)
greater in the Agt one-copy mice than in wild-type (p , 0.05);
(ii) that in the Agt one-copy mice the number of afferent
arterioles with renin-staining cells upstream from the glomer-
ulus is three times that of wild-type mice, and this is highly
significant (p , 0.0001); (iii) that the number of renin-staining
cells along the individual afferent arterioles of the Agt one-copy
mice is also increased significantly (1.4 times wild-type; p ,
0.05); (iv) that the total number of renin-staining cells along
the afferent arterioles of the Agt one-copy mice is more than 4
times wild-type (p , 0.0001).
To assess the possible occurrence of a hyperplastic response
in the renin-containing cells of the JGA of the Agt one-copy
mice, the number of renin-staining cells in a sampling of glo-
meruli having classic donut-shaped JGA was determined by
counting nuclei within the renin-staining areas in Agt one-copy
mice, and this was compared with wild type using the 10-week-
old F2 litter mates. No difference was observed (lower part of
Table II, p . 0.7). To assess the possible occurrence of a hyper-
trophic response, the area of renin staining was determined for
each JGA. Again no difference between the two genotypes was
observed (Table II, p . 0.3). The sizes of the individual renin-
producing cells, as judged by the area per cell, are indistin-
guishable in the classic JGA of the two genotypes. The intensity
of renin-staining per cell was likewise not observably different
in the two genotypes.
FIG. 4. Tissue mRNA levels for secondary tissues synthesizing
AGT and renin determined by RNase protection assay. A, AGT
mRNA levels in the kidney, brain, submandibular gland, and testis; n 5
10 for each group. B, renin mRNA levels in the adrenal gland and
submandibular gland; n 5 10 for each group. The bars show means 6
S.E. Asterisks indicate Agt one-copy means significantly different from
wild-type (p , 0.001).
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Overall these data show that the higher plasma renin levels
and the greater amount of total kidney renin mRNA in the Agt
one-copy animals relative to wild type is mediated by their
having a somewhat greater proportion of glomeruli with renin-
expressing cells in the JGA region and a severalfold greater
number of renin-expressing cells along the afferent arterioles of
their renal glomeruli rather than by hyperplasia or hypertro-
phy of JGA cells already committed to renin synthesis or by
up-regulation of renin gene expression in these cells.
DISCUSSION
The main purpose of the present study was to determine the
major long term adjustments directed toward homeostasis that
occur in mice inheriting a precisely determined genetic varia-
tion with a blood pressure lowering tendency, namely inactiva-
tion of one copy of the Agt gene. The first finding is that in the
liver, the prime site of AGT synthesis, no homeostatic up-
regulation of the remaining functional Agt gene can be detected
at the mRNA level. Thus the single copy of the Agt gene in the
experimental animals yields essentially half the amount of
mRNA achieved by the two copies in the wild-type controls.
This absence of autoregulation of a normal functional gene to
compensate for some unusual behavior in its homologous allele
appears to be very widespread and probably universal in genes
that do not code for products that act directly with their own
regulatory machinery. There is a considerable body of data
from previous studies showing that the expression of many
genes is directly and precisely proportional to gene copy num-
ber. Epstein (43), for example, compiled from previous studies
convincing evidence in support of this proportionality in hu-
mans and mice having trisomies, monosomies, and deletions
involving over 40 different loci mainly coding for enzymes and
plasma proteins. And we, in “gene titration” experiments with
mice, have demonstrated a direct proportionality between gene
copy number and expression with the genes coding for AGT (3,
4), for ACE (44) and for the natriuretic peptide receptor A (45).
In none of these instances is the normal gene up-regulated in
the absence of a functional homologue, while three copies of a
gene produce very close to 1.5 times the amount of immediate
gene product resulting from two copies, indicating a similar
FIG. 5. Renin immunolocalization in the kidneys. A, kidney tissue section from a wild-type mouse. Renin staining (brown) in this type IV
glomerulus is confined to the JGA area. B, kidney tissue section from an Agt one-copy mouse. Renin immunostaining in these type II glomeruli
includes the JGA area but also extends along the afferent arterioles in the direction of the interlobular artery. C, renin immunolocalization within
the renal arteriole tree microdissected from a wild-type mouse. Renin is present mainly in the JGA area (type IV). Renin is not present in
interlobular arteries. D, renin immunolocalization in the renal arteriole tree microdissected from an Agt one-copy mouse. In addition to renin
staining in the juxtaglomerular region (type IV), renin is present in cells along the afferent vessels in distributions corresponding to types II, III,
and mixed types (types II/III and III/IV). Renin is present in interlobular arteries. The diagram below A–D illustrates the types of distribution I
through V.
TABLE II
Renin-staining cells in kidneys of Agt wild-type and Agt one-copy mice
Values are means 6 S.E. Areas are pixels 3 103. Values in paren-
theses are percent relative to wild-type. Counts are averages from two
to four sections from each kidney. n, number of animals; wt, wild-type.
n Agt wt n Agt one-copy
Percent glomeruli with
renin-staining JGA




8 5.0 6 0.6 10 15.5 6 1.4 (310)b
Renin-staining cells per
afferent arteriole
8 6.4 6 0.7 10 9.2 6 0.9 (143)a
Staining cells along
afferent arterioles
8 32 6 5 10 141 6 17 (441)b
Renin-staining cells per
classic JGA
3 4.1 6 0.3 5 4.2 6 0.1 (103)c
Area of JGA 3 1.35 6 0.03 5 1.48 6 0.09 (110)c
Area per JGA cell 3 0.30 6 0.04 5 0.35 6 0.02 (119)c
a p , 0.05 versus wild-type.
b p , 0.0001 versus wild-type.
c p . 0.4 versus wild-type.
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absence of down-regulation. These observations do not exclude
the existence of mechanisms to up-regulate or down-regulate
genes via less direct and more complex pathways, but they do
exclude the general occurrence of autoregulation. The implica-
tion is that most genetic variants which affect expression will
not be corrected by adjusting the transcription of either the
variant gene or its nonvariant homologue.
The second finding is that the major route whereby homeo-
stasis in the endocrine side of the RAS is attempted in the Agt
one-copy animals is through an increase in plasma renin con-
centration mediated by a modest increase in the proportion of
glomeruli with renin-producing cells in their JGA and by the
presence of considerably greater numbers of renin-producing
cells along the afferent glomerular arterioles in the Agt one-
copy animals than in the wild-type animals, rather than by
hyperplasia or hypertrophy of JGA cells already committed to
renin synthesis or by an increase in their renin content. No
significant changes were detected in expression of the Ace gene
or of the gene coding for the type 1A AngII receptor, which
mediates most of the blood pressure-related functions of the
system.
Comment is required on our observation of differences be-
tween the relative expression of the Ren-1 and Ren-2 in the
male but not the female Agt one-copy and wild-type mice. In
assessing the relevance of these findings to the overall problem
of the homeostasis of blood pressure, it is important to recollect
that the androgen-responsive Ren-2 locus has been reported
only in the mouse and then not in all strains. Past work by
others (17, 18) has shown that the Ren-1:Ren-2 expression ratio
differs markedly between different cell types in males but not
in females, ranging from around 1:1 in the male kidney to 1:100
in the male salivary glands. The relative increase in Ren-2
expression seen in the kidneys of male but not the female Agt
one-copy animals suggests that the additional renin-positive
cells along the afferent arterioles have some features like cells
in the salivary glands and so show gender differences in our F1
mice.
Comment is also required on the 4-fold greater amounts of
renin mRNA observed in the adrenals of the male Agt one-copy
animals relative to the expression in their wild-type brothers.
At least two arguments suggest that this increase in renin
expression does not represent a general mechanism for achiev-
ing homeostasis in the circulatory arm of the RAS. First, the
effect is male-limited and is therefore again likely a conse-
quence of the mouse strain-specific androgen-responsive Ren-2
gene. Second, the plasma active renin concentration in the Agt
one-copy males is actually not as much increased (2.2 times
wild type) as in the one-copy females (2.6 times wild type).
However, we do not exclude the possibility that the increased
adrenal expression of renin in the males can act on a local arm of
the RAS (46), and the phenomenon merits further investigation.
Our finding that homeostasis in the genetically modified
animals is accompanied by considerably greater numbers of
renin-producing cells in the kidney alters the nature of subse-
quent questions. In place of asking how up-regulation of the
renin genes in cells already producing renin is induced and
executed in the Agt one-copy animals, the question becomes
what mechanism leads to the observed presence of more renin-
producing cells. No definite answer is available. However, the
changes seen in the normal rat kidney during the period from
late gestation to early maturity and in adult kidneys exposed to
experimentally lowered blood pressures suggest some interest-
ing possibilities. Initially in the developing rat kidney (28) the
afferent glomerular arterioles stain positively for renin along
the whole of their lengths (type I, as illustrated in Fig. 5).
Shortly after birth, type I-staining glomeruli are much less
frequent, but glomeruli can be seen in which the renin staining
extends less far along the arterioles from the glomerulus (type
II). These in turn partly disappear, and glomeruli are seen that
show the classic adult pattern, with renin staining confined to
the JGA (type IV), together with glomeruli showing no renin
staining (type V). The type of renin distribution that is sever-
alfold more frequent in the Agt one-copy mice than in wild type
has a staining pattern very similar to the type II pattern in the
rat. This similarity suggests the possibility that in the Agt
one-copy mice more of the renin-producing cells initially pres-
ent along the afferent arterioles persist into adult life and
fewer glomeruli cease to produce renin in their JGA.
A second possibility is that additional renin-producing cells
are formed in the Agt one-copy mice from non-renin-producing
smooth muscle cells. This type of metaplastic/metamorphic
conversion/recruitment has been described in rat kidneys ex-
posed to blood pressures reduced by partial arterial ligation
(47, 48) and in the kidneys of rats treated with high doses of
ACE inhibitor (23, 49). Cell recruitment has also been demon-
strated in other systems, for example during estrogen-induced
synthesis of apolipoprotein II in avian hepatocytes (50), during
glucose-induced synthesis of pro-insulin in purified pancreatic
beta cells (51), and during thyrotropin-induced formation of
intracellular colloid droplets in thyroid follicular cells (52).
In conclusion, it is clear that much remains to be done if we
are to understand how homeostasis is achieved in the face of
quantitative genetic variations that are likely to be common in
the genes which control our internal environment. The present
results suggest that lifelong genetically determined distur-
bances may be corrected by homeostatic adjustments in the
extent to which different cell populations are retained (or dis-
carded) during development while still allowing disappearance
(or reappearance) of the same cells in maturity if circumstances
change. Attempts to determine the signals and mechanisms
involved in genetic homeostasis should not only look for chronic
up-regulation or down-regulation of immediately relevant
genes, but should also look for possible shifts in the relative
frequencies of the different types of cells that participate in the
system.
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